Pub. Date : 2009 Aug
PMID : 19644472
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | In May 2009, tolvaptan (Samsca; Otsuka), a selective vasopressin V(2) receptor antagonist, was approved by the US FDA for the treatment of clinically significant hypervolaemic and euvolaemic hyponatraemia. | Tolvaptan | arginine vasopressin receptor 2 | Homo sapiens |